SCOPUS 정보 검색 플랫폼

Volumn 13, Issue SUPPL. 2, 2000, Pages 58-61

Chemotherapy of ovarian cancer with respect to results of in vitro chemosensitivity assay - Selected case reports;Chemoterapie ovariálního karcinomu s ohledem na stanovení in vitro chemosensitivity - Vybrané kazuistiky

(10) Cwiertka K a Hajduch M a Pilka, R a Noskova V a Svebisova H a Ludkova A a Machacek J a Kudela, M a Minarik J a Mihal V a

a UNIVERSITY HOSPITAL OLOMOUC (Czech Republic)

Author keywords

Anti cancer chemotherapy; In vitro chemoresistance assay; Multidrug resistance; Ovarial cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; METHYL GROUP; MITOXANTRONE; PACLITAXEL; TETRAZOLIUM; THIAZOLE DERIVATIVE; TOPOTECAN;

ARTICLE; ASSAY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHEMOSENSITIVITY; CLINICAL TRIAL; DISEASE COURSE; DRUG SENSITIVITY; FEMALE; HUMAN; IN VITRO STUDY; OVARY CANCER; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034483575 PISSN: 0862495X EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (4)

References (15)

1
- 0006046317
- (1996) Novotvary

2
- 0006115120
- Naŝe první zkuŝenosti s testováním citlivosti leukemických bunêk na cytostatika
- (1995) Ĉs. Pediat. , vol.50 , pp. 195-200
- Mihál, V.¹ Hajdúch, M.² Weigl, E.³ Videmanová, L.⁴ Šafářová, M.⁵

3
- 0029836277
- Decreased in vitro chemosensitivity of tumour cells in patients suffering from malignant diseases with a poor prognosis
- (1996) Cytotechnology , vol.19 , pp. 243-245
- Hajdúch, M.¹ Mihál, V.² Minařík, J.³ Faber, E.⁴ Šafářová, M.⁵ Weigl, E.⁶ Antálek, P.⁷

4
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N. Engl. J. Med. , vol.334 , pp. 1-6
- Mc Guire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

5
- 0000264166
- Updated analysis shows a highly significant improved overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA, NCIC CTG and Scottish intergroup trial
- abstrakt 1394
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17
- Stuart, G.¹ Bertelsen, K.² Mangioni, C.³ Trope, C.⁴ James, K.⁵ Cassidy, J.⁶ Kaye, S.⁷ Timmers, P.⁸ Roy, J.A.⁹ Piccart, M.J.¹⁰

6
- 0000121237
- Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC)
- A Gynecologic Oncology Group trial (GOG 158) (abstrakt 1373)
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18
- Ozols, R.F.¹ Bundy, B.N.² Fowler, J.³ Clarke-Pearson, D.⁴ Mannel, R.⁵ Hartenbach, E.M.⁶ Baergen, R.⁷

7
- 0006541515
- Randomized Trial of paclitaxel (PTX) and carboplatin (CBDCA) versus a control arm of carboplatin or CAP (cyclophosphamide, doxorubicin & cisplatin): The Third International Collaborative Ovarian Neoplasm Study (ICON 3)
- abstrakt 1500
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19
- Colombo, N.¹

8
- 0025062388
- Heȩs not going to talk about in vitro predictive assays again, is he? Commentary
- (1990) J. Natl. Cancer Inst. , vol.82 , pp. 96-101
- Von Hoff, D.D.¹

9
- 0025051987
- Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician
- (1990) J. Natl. Cancer Inst. , vol.82 , pp. 110-116
- Von Hoff, D.D.¹ Sandbach, J.F.² Clark, G.M.³

10
- 0031805773
- The clinical relevance of chemosensitivity testing in ovarian cancer
- (1998) Cancer Detect. Prev. , vol.22 , pp. 305-312
- Taylor, C.G.¹ Sargent, J.M.² Elgie, A.W.³ Reid, F.D.⁴ Alton, P.A.⁵ Hill, J.G.⁶

11
- 0032168380
- Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer
- (1998) Gynecol. Oncol. , vol.70 , pp. 392-397
- Eltabbakh, G.H.¹ Piver, M.S.² Hempling, R.E.³ Recio, F.O.⁴ Lele, S.B.⁵ Marcheti, D.L.⁶ Baker, T.R.⁷ Blumenson, L.E.⁸

12
- 0033016572
- Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance
- (1999) Cancer J. Sci. Am. , vol.5 , pp. 174-178
- Orr J.W., Jr.¹ Orr, P.² Kern, D.H.³

13
- 0003370945
- Optimized use of paclitaxel and platinum for primary ovarian cancer guided by an ex vivo chemosensitivity assay
- abstrakt 1524
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19
- Kurbacher, C.M.¹ Janát, M.² Brenne, U.³ Cree, I.A.⁴ Andreotti, P.E.⁵ Brucner, H.W.⁶

14
- 0003292896
- EVA-assay-directed therapy of advanced ovarian cancer
- abstrakt 1532
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19
- Dottino, P.¹ Evans, S.S.² Segna, A.³ Beddoe, A.M.⁴ Sommers, B.⁵ Nagourney, R.A.⁶

15
- 4243451095
- Extreme Drug Resistance (EDR) assay to CIS platinum (CP) and survival in ovarian cancer (OC) patients - A comparative analysis
- abstrakt 1579
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19
- Fruehauf, J.P.¹ Saha, S.² Mehta, R.S.³ Nora, D.⁴ Singh, T.⁵ Arora, M.⁶ Wilson, D.⁷ Metz, J.⁸ Ng, P.S.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.